Finance
XChange TEC.INC RECEIVES NASDAQ NOTICE OF REGAINING COMPLIANCE
XChange TEC.INC
MicuRx: Successfully Completes Phase III Clinical Trial of MRX-4 for Injection in China
MicuRx Pharmaceuticals
OIA ANNOUNCES A US$500 MILLION STRATEGIC COLLABORATION WITH TÜRKIYE'S OYAK FUND
Oman Investment Authority